Secondary findings: How did we get here, and where are we going?-Reference-Cited by-同舟云学术

Secondary findings: How did we get here, and where are we going?

Published:2019-03-01 Issue:2 Volume:28 Page:326-333
ISSN:1059-7700
Container-title:Journal of Genetic Counseling
language:en
Short-container-title:J Genet Couns

Author:

Ormond Kelly E.¹^ORCID,O'Daniel Julianne M.²^ORCID,Kalia Sarah S.³⁴^ORCID

Affiliation:

1. Department of Genetics and Stanford Center for Biomedical Ethics; Stanford University School of Medicine; Stanford California

2. Department of Genetics; University of North Carolina at Chapel Hill; Chapel Hill Carolina

3. Department of Epidemiology; Harvard T.H. Chan School of Public Health; Boston Massachusetts

4. Graduate School of Arts and Sciences; Harvard University; Cambridge Massachusetts

Publisher

Wiley

Subject

Genetics (clinical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jgc4.1098/fullpdf

Reference83 articles.

1. Points to consider in the clinical application of genomic sequencing;ACMG Board of Directors;Genetics in Medicine,2012

2. ACMG policy statement: Updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing;ACMG Board of Directors;Genetics in Medicine,2015

3. Ambry Genetics 2011 Ambry genetics first to offer exome sequencing service for clinical diagnostics https://www.prnewswire.com/news-releases/ambry-genetics-first-to-offer-exome-sequencing-service-for-clinical-diagnostics-130780498.html

4. Actionable exomic incidental findings in 6503 participants: Challenges of variant classification;Amendola;Genome Research,2015

5. Incidental findings in clinical genomics: A clarification;American College of Medical Genetics and Genomics;Genetics in Medicine,2013

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic and Genomic Results and Management;Genomics in the Clinic;2024

2. Genomics in reproductive medicine: Current and future applications;Human Reproductive and Prenatal Genetics;2023

3. Significance of the Multi-gene Panel myRisk in Japan;Anticancer Research;2022-07-26

4. A systematic literature review of disclosure practices and reported outcomes for medically actionable genomic secondary findings;Genetics in Medicine;2021-12

5. Burden or benefit? Effects of providing education about and the option to request additional genomic findings from diagnostic exome sequencing: A randomized controlled trial;Patient Education and Counseling;2021-12